Are there any drug interactions between allopurinol and Hiprex (methenamine hippurate), and does Hiprex increase serum uric acid levels?

No Clinically Significant Drug Interaction Between Allopurinol and Hiprex

There is no documented drug interaction between allopurinol and Hiprex (methenamine hippurate), and Hiprex does not elevate uric acid levels. These medications can be safely used together without dose adjustments.

Drug Interaction Assessment

The available evidence does not identify any interaction between allopurinol and methenamine hippurate:

• FDA labeling for allopurinol lists specific drug interactions requiring attention, including mercaptopurine, azathioprine, dicumarol, thiazide diuretics, ampicillin/amoxicillin, cyclophosphamide, chlorpropamide, and cyclosporine 11. Methenamine hippurate is notably absent from this list.

• Known allopurinol interactions involve drugs that either:

  • Are metabolized by xanthine oxidase (mercaptopurine, azathioprine - requiring 65-75% dose reduction) 22
  • Compete for renal tubular excretion (thiazide diuretics, chlorpropamide) 11
  • Affect uric acid excretion (uricosuric agents) 1

• Methenamine hippurate's mechanism involves conversion to formaldehyde in acidic urine for urinary antisepsis 3. This mechanism does not overlap with allopurinol's xanthine oxidase inhibition or renal handling pathways.

Effect of Hiprex on Uric Acid Levels

Hiprex does not elevate serum uric acid levels. The large ALTAR trial (240 women, 12-month treatment) comparing methenamine hippurate to antibiotic prophylaxis for recurrent UTI prevention found no evidence of hyperuricemia as an adverse effect 3. The trial's comprehensive safety monitoring would have detected any clinically significant uric acid elevation.

Common Pitfalls to Avoid

Do not confuse methenamine with pyrazinamide, which does cause significant hyperuricemia through inhibition of renal tubular uric acid secretion. Pyrazinamide actually has a paradoxical interaction with allopurinol - allopurinol can worsen pyrazinamide-induced hyperuricemia by increasing plasma pyrazinoic acid concentrations 45. This is NOT relevant to methenamine hippurate.

Clinical Implications

• No dose adjustments needed for either medication when used concomitantly
• No additional monitoring required beyond standard monitoring for each drug individually
• Allopurinol monitoring should continue as usual: serum uric acid levels, renal function (BUN, creatinine), and liver function if pre-existing liver disease 1
• Hiprex efficacy requires acidic urine (pH < 5.5); this does not affect allopurinol activity

Relevant Allopurinol Interactions to Remember

When prescribing allopurinol, the clinically important interactions requiring action are:

• Mercaptopurine/azathioprine: Reduce dose by 65-75% 21
• Thiazide diuretics: Monitor renal function more closely; may enhance allopurinol toxicity in setting of renal insufficiency 11
• Ampicillin/amoxicillin: Increased risk of skin rash 1
• Cyclophosphamide: Enhanced bone marrow suppression 1